Merck Tbk (MERK)

Currency in IDR
3,980
+60(+1.53%)
Closed·
High dividend Yield
MERK is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3,9204,010
52 wk Range
2,7204,500
Key Statistics
Bid/Ask
3,980.00 / 4,000.00
Prev. Close
3,920
Open
3,940
Day's Range
3,920-4,010
52 wk Range
2,720-4,500
Volume
79.6K
Average Volume (3m)
51.09K
1-Year Change
42.1429%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MERK Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Merck Tbk News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Earnings

Latest Release
Jul 31, 2026
EPS / Forecast
103.59 / --
Revenue / Forecast
347.13B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 743.66%
Dividend Yield
7.02%
Industry Median 5.06%
Annualized payout
275.00
Paid annually
5-Years Growth
+17.65%
Growth Streak

MERK Income Statement

Compare MERK to Peers and Sector

Metrics to compare
MERK
Peers
Sector
Relationship
P/E Ratio
5.4x10.6x−0.3x
PEG Ratio
0.03−0.010.00
Price/Book
1.8x1.6x2.6x
Price / LTM Sales
1.3x1.4x3.1x
Upside (Analyst Target)
-40.9%48.5%
Fair Value Upside
Unlock30.1%6.3%Unlock

PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally. The company operates through Biopharma, Consumer Health, and Others segments. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in research, development, production, and distribution of pharmaceutical and biological prescription medicines to treat colorectal cancer, head and neck cancer, multiple sclerosis, infertility, growth hormone disorders, and diabetes, as well as thyroid disorders, such as hypothyroidism. In addition, it is involved in the office/property leasing and management activities. The company was formerly known as PT Merck Indonesia Tbk and changed its name to PT Merck Tbk in June 2002. The company was founded in 1970 and is based in Jakarta Timur, Indonesia. PT Merck Tbk operates as a subsidiary of Merck Holding GmbH.

Employees
358
Market
Indonesia

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
388.19M86.65%1.52T
Public Companies & Retail Investors
59.81M13.35%234.44B
Total
448M100.00%1.76T

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
E. Merck KG73.99%331,483,0001,299,413,360
Emedia Export Company GmbH12.66%56,711,920222,310,726

People Also Watch

1,375
AMRT
+1.48%
2,730
ISAT
-0.36%
1,965
TPIA
+0.77%
456
DEWA
+3.64%

FAQ

What Is the Merck (MERK) Stock Price Today?

The Merck stock price today is 3,980 IDR.

What Stock Exchange Does Merck Trade On?

Merck is listed and trades on the Jakarta Stock Exchange.

What Is the Stock Symbol for Merck?

The stock symbol for Merck is "MERK."

Does Merck Pay Dividends? What’s The Current Dividend Yield?

The Merck dividend yield is 6.91%.

What Is the Merck Market Cap?

As of today, Merck market cap is 1.78T IDR.

What Is Merck's Earnings Per Share (TTM)?

The Merck EPS (TTM) is 744.

From a Technical Analysis Perspective, Is MERK a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Merck Stock Split?

Merck has split 1 times.

How Many Employees Does Merck Have?

Merck has 358 employees.

What is the current trading status of Merck (MERK)?

As of Aug 20, 2026, Merck (MERK) is trading at a price of 3,980 IDR, with a previous close of 3,920 IDR. The stock has fluctuated within a day range of 3,920 IDR to 4,010 IDR, while its 52-week range spans from 2,720 IDR to 4,500 IDR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.